SAN DIEGO--(BUSINESS WIRE)--Iambic Therapeutics, a clinical-stage biotechnology company developing novel therapeutics using its unique AI-driven discovery platform, today announced Enchant™, a ...
VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc. (“Zymeworks”), a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation ...
The AI drug revolution has the potential to improve clinical successes and human health, but not if it is limited to drug and target discovery in a human-agnostic manner. Scientists should leverage AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results